Literature DB >> 25777586

Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids.

Hes A P Brokx1, Marinus A Paul1, Pieter E Postmus2, Thomas G Sutedja3.   

Abstract

BACKGROUND: Carcinoid of the lung is considered to be a low-grade malignancy. A subgroup presents as an endobronchial tumour. Surgical resection is considered the standard approach because of its metastatic potential and the possibility of an iceberg phenomenon for the endobronchial subgroup. Advances in non-invasive and minimally invasive technologies seem to justify a more lung parenchyma-sparing approach.
METHODS: In patients presenting with bronchial carcinoids, initial bronchoscopic treatment (IBT) is first attempted for complete tumour eradication and sufficient tissue sampling for the proper differentiation of typical (TC) versus atypical (AC) histological type. Furthermore in cases with postobstruction problems the desobstruction is aimed at improving the patient's condition and by that alleviate surgery if that is needed. High resolution CT is performed 6 weeks post IBT to determine local tumour growth. Surgical resection follows in case of extraluminal disease, residual carcinoid inaccessible for IBT, or late recurrences not salvaged by repeat IBT.
RESULTS: Minimum follow-up was 5 years from start of treatment for 112 patients (65 women, 47 men), with a median age of 47 years (range 16-77 years). Eighty-three patients (74%) had TC, and 29 (26%) AC. IBT only was ultimately curative in 42% of the cases (47/112): 42 TC, 5 AC. Disease-specific mortality including surgical mortality has been 2.6% (3/112) in patients with extraluminal carcinoids (3 AC).
CONCLUSIONS: IBT, if with unsuccessful rescue surgery, is justifiable with excellent long-term outcome. IBT made surgery unnecessary in 42% of the cases. Iceberg phenomenon and metastatic potential in this group of patients with bronchial carcinoids are clinically insignificant. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Bronchoscopy; Lung Cancer; Thoracic Surgery

Mesh:

Year:  2015        PMID: 25777586     DOI: 10.1136/thoraxjnl-2014-206753

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Endobronchial Treatment for Bronchial Carcinoid: Patient Selection and Predictors of Outcome.

Authors:  Ellen M B P Reuling; Chris Dickhoff; Peter W Plaisier; Veerle M H Coupé; Albert H A Mazairac; Rutger J Lely; H Jaap Bonjer; Johannes M A Daniels
Journal:  Respiration       Date:  2018-02-12       Impact factor: 3.580

Review 2.  [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].

Authors:  P A Schnabel; K Junker
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

3.  Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.

Authors:  Giacomo Cusumano; Ludovic Fournel; Salvatore Strano; Diane Damotte; Marie Christine Charpentier; Antonio Galia; Alberto Terminella; Maurizio Nicolosi; Jean Francois Regnard; Marco Alifano
Journal:  Lung       Date:  2017-10-11       Impact factor: 2.584

4.  Bronchoscopic resection of typical carcinoid tumors: literature review and case series.

Authors:  Salman Alahmed; Hassan Arishi; Mohammed Alabdulatif; Hana Bamefleh; Raed Alghamdi
Journal:  J Surg Case Rep       Date:  2022-05-17

5.  Cushing's like syndrome in typical bronchial carcinoid a case report and review of the literature.

Authors:  Ilaria Pedicelli; Giuseppina Patriciello; Giovanni Scala; Antonietta Sorrentino; Gennaro Gravino; Pasquale Patriciello; Pio Zeppa; Vincenzo Di Crescenzo; Alessandro Vatrella
Journal:  Int J Surg Case Rep       Date:  2016-02-04

Review 6.  Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms.

Authors:  Johannes Hofland; Gregory Kaltsas; Wouter W de Herder
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

Review 7.  Bronchial Carcinoids: From Molecular Background to Treatment Approach.

Authors:  Marta Araujo-Castro; Eider Pascual-Corrales; Javier Molina-Cerrillo; Nicolás Moreno Mata; Teresa Alonso-Gordoa
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

8.  Multimodality multistaged management of large endobronchial carcinoid causing respiratory failure: A case report with review of literature.

Authors:  Abhijeet Singh; Sivaramakrishnan Mahadevan; Vallandramam R Pattabhiraman; Arjun Srinivasan
Journal:  Lung India       Date:  2018 Sep-Oct

9.  Bronchial carcinoid tumor managed with bronchial artery embolization before endobronchial resection: A case report.

Authors:  Shigehisa Kajikawa; Kojiro Suzuki; Nozomu Matsunaga; Natsuki Taniguchi; Toyonori Tsuzuki; Eisuke Fujishiro; Toshiyuki Yonezawa; Hiroyuki Tanaka; Toshio Kato; Akihito Kubo; Satoru Ito
Journal:  Thorac Cancer       Date:  2021-06-06       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.